Authors : Mariem HACHLAF; Sihame LKHOYAALI; Hajar LEMSYEH; Wydad NADIR; Khaoula TALEB; Chaimae ABDI; Brahim EL GHISSASSI; Hind MRABTI; Saber BOUTAYEB; Hassan ERRIHANI

Volume/Issue : Volume 9 - 2024, Issue 9 - September

Google Scholar : https://tinyurl.com/ytssweyn

Scribd : https://tinyurl.com/2ykjvj8n

DOI : https://doi.org/10.38124/ijisrt/IJISRT24SEP803

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Cancer is a major cause of disease-related malnutrition; the prevalence of malnutrition and muscle loss is high in digestive cancers and is thought to be associated with a poor prognosis. The aim of this prospective study is to investigate changes in dietary habits following a diagnosis of gastrointestinal cancer that are likely to cause or aggravate malnutrition, to assess the existence of restrictive diets involving the permanent elimination of certain essential aliments (meat, dairy products, etc.), to identify the factors that influence patients to adopt them, and to assess the degree to which patients believe in the effectiveness of these diets in curing cancer.  Materials and Methods: 100 patients aged 18 and over, diagnosed with one of the following digestive cancers: colorectal, gastric, pancreatic, oesophageal, hepatocellular carcinoma or biliary tract cancer; were interviewed using an electronic questionnaire.  Results: Among the patients we interviewed, 69% had adopted a restrictive diet following the diagnosis of digestive cancer. The products permanently eliminated included white sugar and/or sweetened foods in 83% of cases, red meat in 80%, tinned food in 77%, dairy products in 61%, spices in 54%, fried food in 49%, white meat and eggs not produced organically in 44%, processed meat in 33%, and all white meat and eggs in 17% and 14% respectively; This diet was recommended mainly by the patient’s entourage (friends and family) in 81% of cases, by other patients and their relatives (58%) and by personal research on the internet in 36% of cases. In addition, 37% of patients believe that this type of diet contributes to curing cancer.  Conclusion: 69% of patients in the study were on a restrictive diet, and more than a third of them believed that this diet could help cure their digestive cancers. Raising awareness among patients and their families is essential to prevent malnutrition and muscle loss, and thus improve the outcome of the cancer.

Keywords : Digestive Cancer, Restrictive Diet, Malnutrition, Sarcopenia.

References :

1. Gascón-Ruiz M, Casas-Deza D, Marti-Pi M, Torres-Ramón I, Zapata-García M, Sesma A, Lambea J, Álvarez-Alejandro M, Quilez E, Isla D, Arbonés-Mainar JM. Diagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer Outpatients. Biomedicines. 2022 Sep 6;10(9):2201. doi: 10.3390/biomedicines 10092201. PMID: 36140301; PMCID: PMC 9496397.
2. Schaible U.E., Kaufmann S.H. Malnutrition and infection: Complex mechanisms and global impacts. PLoS Med. 2007;4:e115. doi: 10.1371/journal.pmed. 0040115. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Katona P., Katona-Apte J. The interaction between nutrition and infection. Clin. Infect. Dis. 2008;46:1582–1588. doi: 10.1086/587658. [PubMed] [CrossRef] [Google Scholar]
4. de Las Peñas R., Majem M., Perez-Altozano J., Virizuela J.A., Cancer E., Diz P., Donnay O., Hurtado A., Jimenez-Fonseca P., Ocon M.J. SEOM clinical guidelines on nutrition in cancer patients (2018) Clin. Transl. Oncol. 2019;21:87–93. doi: 10.1007/s12094-018-02009-3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. Arends J., Bachmann P., Baracos V., Barthelemy N., Bertz H., Bozzetti F., Fearon K., Hütterer E., Isenring E., Kaasa S., et al. ESPEN guidelines on nutrition in cancer patients. Clin. Nutr. 2017;36:11–48. doi: 10.1016/j.clnu.2016.07.015. [PubMed] [CrossRef] [Google Scholar]
6. Haiducu C, Buzea A, Mirea LE, Dan GA. The prevalence and the impact of sarcopenia in digestive cancers. A systematic review. Rom J Intern Med. 2021 Nov 20;59(4):328-344. doi: 10.2478/rjim-2021-0026. PMID: 34218540.
7. Andreyev HJ, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998;34:503e9.
8. Pressoir M, Desne S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centres. Br J Cancer 2010;102:966e71.
9. Suzuki H., Asakawa A., Amitani H., Nakamura N., Inui A. Cancer cachexia—Pathophysiology and management. J. Gastroenterol. 2013;48:574–594. doi: 10.1007/s00535-013-0787-0. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
10. Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187– 1196. doi: 10.1016/j.clnu.2017.06.017. [PubMed] [CrossRef] [Google Scholar]
11. Ford KL, Arends J, Atherton PJ, Engelen MPKJ, Gonçalves TJM, Laviano A, Lobo DN, Phillips SM, Ravasco P, Deutz NEP, Prado CM. The importance of protein sources to support muscle anabolism in cancer: An expert group opinion. Clin Nutr. 2022 Jan;41(1):192-201. doi: 10.1016/j.clnu.2021.11.032. Epub 2021 Nov 29. PMID: 34891022.
12. Williams JP, Phillips BE, Smith K, Atherton PJ, Rankin D, Selby AL, Liptrot S, Lund J, Larvin M, Rennie MJ. Effect of tumor burden and subsequent surgical resection on skeletal muscle mass and protein turnover in colorectal cancer patients. Am J Clin Nutr. 2012 Nov;96(5):1064-70. doi: 10.3945/ajcn.112.045708. Epub 2012 Oct 3. PMID: 23034966.
13. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):129-133. doi: 10.1007/s13539-010-0014-2. Epub 2010 Dec 17. PMID: 21475695; PMCID: PMC3060646
14. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169. Erratum in: Age Ageing. 2019 Jul 1;48(4):601. doi: 10.1093/ageing/afz046. PMID: 30312372; PMCID: PMC6322506.
15. Heymsfield SB, Wang Z, Baumgartner RN, Ross R. Human body composition: advances in models and methods. Annu Rev Nutr. 1997;17:527-58. doi: 10.1146/annurev.nutr.17.1.527. PMID: 9240939.
16. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008 Jul;9(7):629-35. doi: 10.1016/S1470-2045(08)70153-0. Epub 2008 Jun 6. PMID: 18539529.
17. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus framework. Lancet Oncol 2011;12:489e95
18. Cederholm T., Jensen G.L., Correia M.I.T.D., Gonzalez M.C., Fukushima R., Higashiguchi T., Baptista G., Barazzoni R., Blaauw R., Coats A.J., et al. GLIM criteria for the diagnosis of malnutrition—A consensus report from the global clinical nutrition community. Clin. Nutr. 2019;38:1–9. doi: 10.1016/j.clnu.2018.08.002.
19. Rier HN, Jager A, Sleijfer S, Maier AB, Levin MD. The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature. Oncologist. 2016 Nov;21(11):1396-1409. doi:10.1634/theoncologist.2016-0066. Epub 2016 Jul 13. PMID: 27412391; PMCID: PMC5189631.
20. Wang H, Yang R, Xu J, Fang K, Abdelrahim M, Chang L. Sarcopenia as a predictor of postoperative risk of complications, mortality and length of stay following gastrointestinal oncological surgery. Ann R Coll Surg Engl. 2021 Oct;103(9):630-637. doi: 10.1308/rcsann.2021.0082. Epub 2021 Mar 19. PMID: 33739153; PMCID: PMC10335206.
21. Kim IH, Choi MH, Lee IS, Hong TH, Lee MA. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study. BMC Cancer. 2021 Jan 18;21(1):77. doi: 10.1186/s12885- 020-07753-w. PMID: 33461517; PMCID: PMC7814715.
22. Nilsson MP, Johnsson A, Scherman J. Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer. Radiat Oncol. 2021 Aug 16;16(1):152. doi: 10.1186/s13014-021-01876-5. PMID: 34399812; PMCID: PMC8365937
23. Zick SM, Snyder D, Abrams DI. Pros and Cons of Dietary Strategies Popular Among Cancer Patients. Oncology (Williston Park). 2018 Nov 15;32(11):542-7. PMID: 30474102.
24. Bishop FL, Rea A, Lewith H, Chan YK, Saville J, Prescott P, von Elm E, Lewith GT. Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies. Prostate Cancer Prostatic Dis. 2011 Mar;14(1):1-13. doi: 10.1038/pcan.2010.38. Epub 2010 Oct 19. PMID: 20956994.
25. Mueller CM, Mai PL, Bucher J, et al. Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer. BMC Complement Altern Med. 2008;8:17
26. Sullivan ES, Rice N, Kingston E, Kelly A, Reynolds JV, Feighan J, et al. A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journey. Clin Nutr ESPEN 2021;41:331e9
27. Ghelfi F, Tieri M, Gori S, Nicolis F, Petrella MC, Filiberti A, et al. Do cancer patients change their diet in the e-health information era? A review of the literature and a survey as a proposal for the Italian population. Food Res Int 2018;104:59e68
28. Salminen EK, Lagstrom HK, Heikkil a SP, Salminen SJ. Does breast cancer change patients' dietary habits? Eur J Clin Nutr 2000;54:844e8. https://doi.org/10.1038/sj.ejcn.1601103.
29. Bours MJ, Beijer S, Winkels RM, Van Duijnhoven FJ, Mols F, BreedveldPeters JJ, et al. Dietary changes and dietary supplement use, and underlying motives for these habits reported by colorectal cancer survivors of the Patient Reported Outcomes Following Initial Treatment and Long-Term Evaluation of Survivorship (PROFILES) registry. Br J Nutr 2015;114:286e96.
30. Gavazzi C, Sieri S, Traclo F, Sproviero A, Vandoni G, Ricci R, et al. Changes in food habits in cancer patients in Italy: an AIOM-SINPE-FAVO survey. Nutrition 2018;55e56:140e5
31. van Zutphen M, Boshuizen HC, Kok DE, van Baar H, Geijsen AJMR, Wesselink E, et al. Colorectal cancer survivors only marginally change their overall lifestyle in the first 2 years following diagnosis. J Cancer Surviv2019;13:956e67
32. van Veen MR, Winkels RM, Janssen SHM, Kampman E, Beijer S. Nutritional information provision to cancer patients and their relatives can promote dietary behavior changes independent of nutritional information needs. Nutr Cancer 2018;70:483e9
33. Muscaritoli M., Amabile M.I., Molfino A. Foods and their components promoting gastrointestinal cancer. Curr. Opin. Clin. Nutr. Metab. Care. 2016;19:377–381. doi: 10.1097/MCO.0000000000000309.
34. Huxley R.R., Ansary-Moghaddam A., Clifton P., Czernichow S., Parr C.L., Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence. Int. J. Cancer. 2009;125:171–180. doi: 10.1002/ijc.24343.
35. Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Norat T. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One. 2011;6(6):e20456. doi: 10.1371/journal.pone.0020456. Epub 2011 Jun 6. PMID: 21674008; PMCID: PMC3108955.
36. Sun Y, He X, Sun Y. Red and processed meat and pancreatic cancer risk: a meta-analysis. Front Nutr. 2023 Sep 27;10:1249407. doi: 10.3389/fnut.2023.1249407. PMID: 37829734; PMCID: PMC10565855.
37. Kim Y. The association between red, processed and white meat consumption and risk of pancreatic cancer: a meta-analysis of prospective cohort studies. Cancer Causes Control. 2023 Jul;34(7):569-581. doi: 10.1007/s10552-023-01698-8. Epub 2023 Apr 18. PMID: 37071321.
38. Zhao Z, Yin Z, Zhao Q. Red and processed meat consumption and gastric cancer risk: a systematic review and meta-analysis. Oncotarget. 2017 May 2;8(18):30563-30575. doi: 10.18632/oncotarget.15699. PMID: 28430644; PMCID: PMC5444765.
39. Clemente-Suárez VJ, Beltrán-Velasco AI, Redondo-Flórez L, Martín-Rodríguez A, TorneroAguilera JF. Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review. Nutrients. 2023 Jun 14;15(12):2749. doi: 10.3390/nu15122749. PMID: 37375654; PMCID: PMC10302286
40. Meyerhardt J.A., Niedzwiecki D., Hollis D., Saltz L.B., Hu F.B., Mayer R.J., Nelson H., Whittom R., Hantel A., Thomas J., et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007;298:754–764. doi: 10.1001/jama.298.7.754
41. Fung T.T., Kashambwa R., Sato K., Chiuve S.E., Fuchs C.S., Wu K., Giovannucci E., Ogino S., Hu F.B., Meyerhardt J.A. Post diagnosis diet quality and colorectal cancer survival in women. PLoS ONE. 2014;9:115377. doi: 10.1371/journal.pone.0115377
42. Fung T.T., Rimm E.B., Spiegelman D., Rifai N., Tofler G.H., Willett W.C., Hu F.B. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am. J. Clin. Nutr. 2001;73:61–67. doi: 10.1093/ajcn/73.1.61.
43. Sandhu M.S., Dunger D.B., Giovannucci E.L. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J. Natl. Cancer Inst. 2002;94:972–980. doi: 10.1093/jnci/94.13.972.
44. The Facts about Food after Cancer Diagnosis: A Systematic Review of Prospective Cohort Studies. Rinninella E, Mele MC, Cintoni M, Raoul P, Ianiro G, Salerno L, Pozzo C, Bria E, Muscaritoli M, Molfino A, Gasbarrini A. Nutrients. 2020 Aug 5;12(8):2345. doi: 10.3390/nu12082345. PMID: 32764484
45. Ratjen I., Schafmayer C., di Giuseppe R., Waniek S., Plachta-Danielzik S., Koch M., Nöthlings U., Hampe J., Schlesinger S., Lieb W. Postdiagnostic Mediterranean, and Healthy Nordic Dietary Patterns Are Inversely Associated with All-Cause Mortality in Long-Term Colorectal Cancer Survivors. J. Nutr. 2017;147:636–644. doi: 10.3945/jn.116.244129
46. Song M., Wu K., Meyerhardt J., Ogino S., Wang M., Fuchs C.S., Giovannucci E.L., Chan A.T. Fiber Intake and Survival After Colorectal Cancer Diagnosis. JAMA Oncol. 2018;4:71–79. doi: 10.1001/jamaoncol.2017.3684
47. Song M., Wu K., Meyerhardt J., Ogino S., Wang M., Fuchs C.S., Giovannucci E.L., Chan A.T. Fiber Intake and Survival After Colorectal Cancer Diagnosis. JAMA Oncol. 2018;4:71–79. doi: 10.1001/jamaoncol.2017.3684
48. Farinetti A., Zurlo V., Manenti A., Coppi F., Mattioli A.V. Mediterranean diet and colorectal cancer: A systematic review. Nutrition. 2017;43:83–88. doi: 10.1016/j.nut.2017.06.008
49. Fung T.T., McCullough M.L., Newby P.K., Manson J.E., Meigs J.B., Rifai N., Willett W.C., Hu F.B. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am. J. Clin. Nutr. 2005;82:163–173. doi: 10.1093/ajcn/82.1.163.
50. McCullough M.L., Gapstur S.M., Shah R., Jacobs E.J., Campbell P.T. Association between red and processed meat intake and mortality among colorectal cancer survivors. J. Clin. Oncol. 2013;31:2773–2782. doi: 10.1200/JCO.2013. 49.1126.
51. Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment. Carr PR, Jansen L, Walter V, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. Am J Clin Nutr. 2016 Jan;103(1):192- 200. doi: 10.3945/ajcn.115.121145. Epub 2015 Nov 25. PMID: 26607936
52. Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival. Zoltick ES, Smith-Warner SA, Yuan C, Wang M, Fuchs CS, Meyerhardt JA, Chan AT, Ng K, Ogino S, Stampfer MJ, Giovannucci EL, Wu K. Br J Cancer. 2021 Sep;125(7):1016-1024. doi: 10.1038/s41416-021-01487-7. Epub 2021 Jul 15. PMID: 34267328
53. Meyerhardt JA, Sato K, Niedzwiecki D, Ye C, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Venook A, Fuchs CS. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012 Nov 21;104(22):1702-11. doi: 10.1093/jnci/djs399. Epub 2012 Nov 7. PMID: 23136358; PMCID: PMC3502194.
54. Yang B., McCullough M.L., Gapstur S.M., Jacobs E.J., Bostick R.M., Fedirko V., Flanders W.D., Campbell P.T. Calcium, vitamin D, dairy products, and mortality among colorectal cancer survivors: The Cancer Prevention Study-II Nutrition Cohort. J. Clin. Oncol. 2014;32:2335– 2343. doi: 10.1200/JCO.2014.55.3024.
55. Shukla S.K., Gebregiworgis T., Purohit V., Chaika N.V., Gunda V., Radhakrishnan P., Mehla K., Pipinos I.I., Powers R., Yu F., et al. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab. 2014;2:18. doi: 10.1186/2049-3002-2- 18.
56. A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice. Natalia E Cortez , Suraj Pathak , Cecilia Rodriguez Lanzi , Brian V Hong , Ryman Crone, Rasheed Sule , Fangyi Wang , Shuai Chen , Aldrin V Gomes , Keith Baar , Gerardo G Mackenzie PMID: 37445930 PMCID: PMC10341838 DOI: 10.3390/ijms241310753
57. van Vliet S, Burd NA, van Loon LJ. The Skeletal Muscle Anabolic Response to Plant- versus Animal-Based Protein Consumption. J Nutr. 2015 Sep;145(9):1981-91. doi: 10.3945/jn.114.204305. Epub 2015 Jul 29. PMID: 26224750.
58. FAO/WHO. Protein quality evaluation: report of the joint FAO/WHO expert consultation 1989. Rome, Italy: FAO; 1991